Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China flag China · Delayed Price · Currency is CNY
3.250
+0.060 (1.88%)
Sep 30, 2026, 3:04 PM CST

SHE:300026 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
1,6761,5021,3061,5741,2061,316
Cash & Short-Term Investments
1,6761,5021,3061,5741,2061,316
Cash Growth
26.32%15.00%-17.00%30.46%-8.34%16.89%
Accounts Receivable
2,4612,5722,8252,8923,5463,694
Other Receivables
28.133.6138.3450.0949.9459.23
Receivables
2,4892,6062,8642,9423,5963,753
Inventory
1,3511,3711,7491,9612,2141,305
Prepaid Expenses
17.6313.5512.513.2532.1116.77
Other Current Assets
233.42224.12217.18230.06336.93416.22
Total Current Assets
5,7675,7176,1496,7207,3856,806
Property, Plant & Equipment
2,8592,9533,1493,2423,3222,901
Long-Term Investments
174.02178.84235.58247.62244.03272.82
Goodwill
629.39635.6675.2692.54716.05716.05
Other Intangible Assets
247.85267.14298.45331.11352.73313.68
Long-Term Accounts Receivable
5.215.2126.3946.3794.1115.01
Long-Term Deferred Tax Assets
235.17223.41222.17129.29140.56108.16
Long-Term Deferred Charges
386.74393.54386.75402.6327.29311.53
Other Long-Term Assets
24.2618.0222.7723.1477.6862.51
Total Assets
10,32810,39211,16511,83512,66011,607

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
528.66449.97678.15713.45884.77605
Accrued Expenses
230.47268.52299.23184.08444.37519.36
Short-Term Debt
31.9814.8516.2423.18231.47293.79
Current Portion of Long-Term Debt
72.51116.65150.25167.67380.77100.02
Current Portion of Leases
42.0136.7545.2525.8855.0745.86
Current Income Taxes Payable
6.8810.2719.420.619.8215.12
Current Unearned Revenue
70.6852.0363.9776.27208.03137.56
Other Current Liabilities
336.11332.6348.67353.7463.6341.56
Total Current Liabilities
1,3191,2821,6211,5652,6782,058
Long-Term Debt
143.51260.59529.171,2571,3451,458
Long-Term Leases
96.23102.25111.1659.4278.1267.07
Long-Term Unearned Revenue
57.5662.0365.5662.5662.0467.55
Long-Term Deferred Tax Liabilities
28.6131.2839.5223.233.813.95
Total Liabilities
1,6451,7382,3672,9674,1973,655

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
3,0043,0043,0043,0043,0043,004
Additional Paid-In Capital
589.89589.89589.89589.49589.49589.49
Retained Earnings
5,0194,9715,0435,1124,6954,199
Comprehensive Income & Other
-54.39-48.796.834.750.86-19.98
Total Common Equity
8,5598,5178,6448,7108,2907,773
Minority Interest
124.05137.68154.66157.7172.87179.49
Shareholders' Equity
8,6838,6548,7998,8688,4637,952
Total Liabilities & Equity
10,32810,39211,16511,83512,66011,607

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
386.24531.1852.071,5332,0911,965
Net Cash (Debt)
1,289971.06454.1240.24-884.45-648.87
Net Cash Growth
96.19%113.83%1028.45%---
Net Cash Per Share
0.700.530.210.01-0.30-0.22
Filing Date Shares Outstanding
3,0043,0043,0043,0043,0043,004
Total Common Shares Outstanding
3,0043,0043,0043,0043,0043,004
Working Capital
4,4484,4354,5285,1554,7074,748
Book Value Per Share
2.852.832.882.902.762.59
Tangible Book Value
7,6827,6147,6707,6867,2216,743
Tangible Book Value Per Share
2.562.532.552.562.402.24
Buildings
1,9792,0001,9861,9881,7301,651
Machinery
2,5362,5522,5442,5142,1551,852
Construction In Progress
175.31130.89104.1954.11461.01232.93